Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population
Authors' conclusion
Adoption of CGM and HCL was associated with decreased A1C, suggesting promotion of these technologies may yield glycemic benefits.
Study context
- Population
- Patients aged <22 years with T1D duration >3 months, single center; grouped by MDI or insulin pump, with or without hybrid closed-loop (HCL), and blood glucose monitor or CGM1,455 patients
- Participants
- 2,827 vs 2,731
- Exposure
- Technology use and HbA1c in 2016-2017 vs 2020-2021
- 2016-2017n = 2,827reference
- 2020-2021n = 2,731
- Outcome
- Glycemic control (HbA1c)
Methodological detailssingle-centre, linear mixed-effects models adjusted for age, diabetes duration and race/ethnicity
- Single-centre
- Linear mixed-effects models adjusted for age, diabetes duration and race/ethnicity
Main finding
As reported in the abstract
Overall A1C · 2016-2017 to 2020-2021
Overall A1C decreased
from 8.9 to 8.6%
P < 0.0001
Observational data: associations, not effects.
Further findings
CGM use · 2016-2017 to 2020-2021
- CGM use increased
- from 32.9 to 75.3%
HCL use · 2016-2017 to 2020-2021
- HCL use increased
- from 0.3 to 27.9%
Original publication
Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population. Diabetes Care. Published 6 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →